The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
News|Articles|April 25, 2014
Exhibits Drive Attendee Action at Interphex 2014
Author(s)Pharmaceutical Technology Editors
INTERPEHX 2014 attendees tested their driving skills in a racecar simulator at the Federal Equipment booth.
Advertisement
Visitors to INTERPEHX 2014 tested their driving skills in a racecar simulator at the Federal Equipment booth. Pharmaceutical Technology’s publisher, Mike Tracey (pictured) was a participant.
INTERPHEX 2014 attracted 12,000 attendees to more that 650 exhibitors at the Javits Center in New York City on March 18-20. INTERPHEX 2015 will be held April 21-23 in New York.
Federal Equipment has more than 50 years of experience in the processing equipment industry, providing used equipment for solid dose, sterile, API and related pharmaceutical process industries.
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement